Study: Low-dose PET/CT best for lymphoma staging

12/8/2008 | Diagnostic Imaging

A Spanish study found that low-dose PET/CT achieved the best sensitivity and specificity for the initial staging of biopsy-proven non-Hodgkin's lymphoma and Hodgkin's lymphoma compared with contrast-enhanced CT. This imaging method could reduce the radiation dose and eliminate the need for intravenous iodinated contrast materials, the lead researcher said.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID